Bliss GVS Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the exchanges that its trading window for insiders, designated persons, and their immediate relatives will be closed starting Thursday, January 1, 2026. The closure will remain in effect until 48 hours after the company announces its unaudited financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). This is done as per SEBI's insider trading regulations. The board meeting date to approve these Q3 results will be communicated separately.
This is a routine regulatory compliance announcement and does not directly affect retail shareholders. Investors should watch for the upcoming Q3 FY26 earnings announcement, which is typically the next material event for the stock.